546 related articles for article (PubMed ID: 18063918)
1. Liver X receptors (LXRs). Part I: structure, function, regulation of activity, and role in lipid metabolism.
Wójcicka G; Jamroz-Wiśniewska A; Horoszewicz K; Bełtowski J
Postepy Hig Med Dosw (Online); 2007 Dec; 61():736-59. PubMed ID: 18063918
[TBL] [Abstract][Full Text] [Related]
2. Liver X receptors (LXR) as therapeutic targets in dyslipidemia.
Bełtowski J
Cardiovasc Ther; 2008; 26(4):297-316. PubMed ID: 19035881
[TBL] [Abstract][Full Text] [Related]
3. Biological role of liver X receptors.
Baranowski M
J Physiol Pharmacol; 2008 Dec; 59 Suppl 7():31-55. PubMed ID: 19258656
[TBL] [Abstract][Full Text] [Related]
4. Liver X receptors (LXRs). Part II: non-lipid effects, role in pathology, and therapeutic implications.
Jamroz-Wiśniewska A; Wójcicka G; Horoszewicz K; Bełtowski J
Postepy Hig Med Dosw (Online); 2007 Dec; 61():760-85. PubMed ID: 18063919
[TBL] [Abstract][Full Text] [Related]
5. Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.
Green CD; Jump DB; Olson LK
Endocrinology; 2009 Jun; 150(6):2637-45. PubMed ID: 19228891
[TBL] [Abstract][Full Text] [Related]
6. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta.
Repa JJ; Liang G; Ou J; Bashmakov Y; Lobaccaro JM; Shimomura I; Shan B; Brown MS; Goldstein JL; Mangelsdorf DJ
Genes Dev; 2000 Nov; 14(22):2819-30. PubMed ID: 11090130
[TBL] [Abstract][Full Text] [Related]
7. Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells.
Panzenboeck U; Kratzer I; Sovic A; Wintersperger A; Bernhart E; Hammer A; Malle E; Sattler W
Int J Biochem Cell Biol; 2006; 38(8):1314-29. PubMed ID: 16530456
[TBL] [Abstract][Full Text] [Related]
8. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
[TBL] [Abstract][Full Text] [Related]
10. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
[TBL] [Abstract][Full Text] [Related]
11. Liver X receptors as therapeutic targets in metabolism and atherosclerosis.
Nomiyama T; Bruemmer D
Curr Atheroscler Rep; 2008 Feb; 10(1):88-95. PubMed ID: 18366990
[TBL] [Abstract][Full Text] [Related]
12. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.
Lund EG; Peterson LB; Adams AD; Lam MH; Burton CA; Chin J; Guo Q; Huang S; Latham M; Lopez JC; Menke JG; Milot DP; Mitnaul LJ; Rex-Rabe SE; Rosa RL; Tian JY; Wright SD; Sparrow CP
Biochem Pharmacol; 2006 Feb; 71(4):453-63. PubMed ID: 16325781
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptor modulators: effects on lipid metabolism and potential use in the treatment of atherosclerosis.
Fiévet C; Staels B
Biochem Pharmacol; 2009 Apr; 77(8):1316-27. PubMed ID: 19101522
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptors, atherosclerosis and inflammation.
Michael DR; Ashlin TG; Buckley ML; Ramji DP
Curr Atheroscler Rep; 2012 Jun; 14(3):284-93. PubMed ID: 22419222
[TBL] [Abstract][Full Text] [Related]
15. Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor.
Quinet EM; Savio DA; Halpern AR; Chen L; Miller CP; Nambi P
J Lipid Res; 2004 Oct; 45(10):1929-42. PubMed ID: 15292374
[TBL] [Abstract][Full Text] [Related]
16. The nuclear receptor LXR is a glucose sensor.
Mitro N; Mak PA; Vargas L; Godio C; Hampton E; Molteni V; Kreusch A; Saez E
Nature; 2007 Jan; 445(7124):219-23. PubMed ID: 17187055
[TBL] [Abstract][Full Text] [Related]
17. Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP.
Zanotti I; Potì F; Favari E; Steffensen KR; Gustafsson JA; Bernini F
J Pharmacol Exp Ther; 2006 Apr; 317(1):395-401. PubMed ID: 16415093
[TBL] [Abstract][Full Text] [Related]
18. Induction of SREBP-1c mRNA by differentiation and LXR ligand in human keratinocytes.
Yokoyama A; Makishima M; Choi M; Cho Y; Nishida S; Hashimoto Y; Terui T
J Invest Dermatol; 2009 Jun; 129(6):1395-401. PubMed ID: 19242521
[TBL] [Abstract][Full Text] [Related]
19. Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells.
Delvecchio CJ; Bilan P; Radford K; Stephen J; Trigatti BL; Cox G; Parameswaran K; Capone JP
Mol Endocrinol; 2007 Jun; 21(6):1324-34. PubMed ID: 17405904
[TBL] [Abstract][Full Text] [Related]
20. Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator.
Miao B; Zondlo S; Gibbs S; Cromley D; Hosagrahara VP; Kirchgessner TG; Billheimer J; Mukherjee R
J Lipid Res; 2004 Aug; 45(8):1410-7. PubMed ID: 15145986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]